Absolute biomarker concentrations in the total population and according to glucose metabolism, weight, metabolic syndrome and smoking status as determined by the single-biomarker techniques or by the multi-array platform of MesoScaleDiscovery.

Data are means ± SD or medians [interquartile range].aNGM, normal glucose metabolism: defined as fasting plasma glucose bCategorized on the basis of individuals’ body mass index (BMI) as: normal (if BMI 18.5–24.9 kg/m2); overweight (if BMI ≥25.0 and 2), and obese (if BMI ≥30 kg/m2);cMetabolic syndrome status was defined according to the revised NCEP-ATPIII definition (American Heart Association/National Heart, Lung and Blood Institute);dany 3 out of the following traits/risk factors reflect the presence of the syndrome: elevated waist circumference (≥102 cm in men, ≥88 cm in women); reduced HDL-cholesterol (